Announcements Trials

Browse Landscape

Phase

Phase 2 41 Phase 1/2 13 Phase 1 13 Phase 3 6 Phase NA 3 Phase 2/3 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Completed 2 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Saline Solution 6 Fentanyl 6 Sodium Chloride 5 Letrozole 5 Dexamethasone 5 Pregabalin 4 Ketamine 4 Goserelin 4 Gemcitabine 4 Bevacizumab 4 Tranexamic Acid 3 Photochemotherapy 3 Pemetrexed 3 Paclitaxel 3 Metformin 3 Leuprolide 3 Docetaxel 3 Cyclophosphamide 3 Carboplatin 3 Capecitabine 3 Acetaminophen 3 ulipristal acetate 2 sodium glycididazole 2 nilotinib 2 liposomal doxorubicin 2 human papillomavirus vaccine, L1 type 16, 18 2 flurbiprofen axetil 2 fludarabine 2 fluciclovine F-18 2 epoetin beta 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Melphalan × Clear all

NCT02773550 2020-01-18

Velcadito

Basque Health Service

Phase 4 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡